Vanda Pharmaceuticals
VNDA
#7906
Rank
S$0.45 B
Marketcap
S$7.55
Share price
0.17%
Change (1 day)
28.58%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are S$0.21 Billion. In 2024 the company made an earning of -S$52.18 Million a decrease over its 2023 earnings that were of -S$17.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion203.54%
2024 -S$52.18 Million191.43%
2023 -S$17.91 Million-320.45%
2022 S$8.12 M-84.99%
2021 S$54.1 M54.8%
2020 S$34.95 M19.42%
2019 S$29.26 M4.93%
2018 S$27.89 M-228.6%
2017 -S$21.69 Million-8.98%
2016 -S$23.84 Million-53.79%
2015 -S$51.57 Million-30.18%
2014 -S$73.86 Million173.08%
2013 -S$27.05 Million-25.33%
2012 -S$36.22 Million163.61%
2011 -S$13.74 Million-221.15%
2010 S$11.34 M-124.53%
2009 -S$46.24 Million-29.44%
2008 -S$65.53 Million-36.2%
2007 -S$0.11 Billion21.81%
2006 -S$84.32 Million170.55%
2005 -S$31.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.33 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.25 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.59 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.93 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.87 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.31 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-S$3.6 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA